Vident Investment Advisory, LLC Alector, Inc. Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$5.86 - $7.93 $19,537 - $26,438
3,334 Added 28.79%
14,916 $89,000
Q1 2023

May 15, 2023
BUY
$5.85 - $9.84 $830 - $1,397
142 Added 1.24%
11,582 $71,000
Q4 2022

Feb 14, 2023
BUY
$6.88 - $9.55 $8,173 - $11,345
1,188 Added 11.59%
11,440 $105,000
Q3 2022

Nov 14, 2022
BUY
$8.19 - $13.2 $83,963 - $135,326
10,252 New
10,252 $97,000
Q3 2021

Nov 12, 2021
SELL
$21.65 - $39.49 $219,184 - $399,796
-10,124 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$15.5 - $22.48 $156,922 - $227,587
10,124 New
10,124 $211,000

Others Institutions Holding ALEC

# of Institutions
170
Shares Held
57.8M
Call Options Held
146K
Put Options Held
90.8K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $148M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email